-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:DoorDash公布了2026财年第一季度业绩,表现喜忧参半。营收为40.4亿美元(同比增长33%),低于市场普遍预期的41.5亿美元;尽管同比下降5%且计入4800万美元重组费用,但GAAP每股收益仍高于华尔街预期的0.36美元。市场总收入为316亿美元(同比增长37%,剔除Deliveroo后增长24%),调整后EBITDA为7.54亿美元(同比增长28%),均高于公司此前给出的314亿美元和7.25亿美元的预期中值。各主要垂直领域的运营表现依然强劲,美国杂货和零售业务吸引了创纪录的新用户,同时实现了单位经济效益的提升和持续的总收入增长。第二季度业绩指引显示公司延续了增长势头,预计调整后 EBITDA 为 8.2 亿美元(高于市场预期的 7.42 亿美元),公司总收入为 329 亿美元(同比增长 36%),这一结果令人鼓舞,此前第一季度业绩指引低于预期。我们预计 Deliveroo 的整合成本和平台投资的增加将持续挤压利润率,但我们相信随着整合成本的正常化和运营杠杆的改善,这些利润率压力只是暂时的。
Related Articles
StarHub's Net Attributable Profit Falls 81% in Q1
StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.
Meesho Narrows Consolidated Loss in Fiscal Q4
Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.
Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug
Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.